Isoallopregnanolone Inhibits Estrus Cycle-Dependent Aggressive Behavior
Biomolecules · 2023
DOI: 10.3390/biom13061017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Torbjörn Bäckström und 7 weiteren Autor:innen. Beteiligte Einrichtung: Umeå Neurosteroid Research Center, Department of Clinical Science, Umeå University, SE-901 85 Umea, Sweden. Hauptthemen laut MEDLINE: Receptors, GABA-A, Aggression. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSRD VA, Medical Research Council, EU grant Horizon 2020 project.
Abstract (Originalsprache)
Among female rats, some individuals show estrus cycle-dependent irritability/aggressive behaviors, and these individual rats may be used as a model for premenstrual dysphoric disorder (PMDD). We wanted to investigate if these behaviors are related to the estrus cycle phase containing moderately increased levels of positive GABA-A receptor-modulating steroids (steroid-PAM), especially allopregnanolone (ALLO), and if the adverse behavior can be antagonized. The electrophysiology studies in this paper show that isoallopregnanolone (ISO) is a GABA-A-modulating steroid antagonist (GAMSA), meaning that ISO can antagonize the agonistic effects of positive GABA-A receptor-modulating steroids in both α1β2γ2L and α4β3δ GABA-A receptor subtypes. In this study, we also investigated whether ISO could antagonize the estrus cycle-dependent aggressive behaviors in female Wistar rats using a resident–intruder test. Our results confirmed previous reports of estrus cycle-dependent behaviors in that 42% of the tested rats showed higher levels of irritability/aggression at diestrus compared to those at estrus. Furthermore, we found that, during the treatment with ISO, the aggressive behavior at diestrus was alleviated to a level comparable to that of estrus. We noticed an 89% reduction in the increase in aggressive behavior at diestrus compared to that at estrus. Vehicle treatment in the same animals showed a minimal effect on the diestrus-related aggressive behavior. In conclusion, we showed that ISO can antagonize Steroid-PAM both in α1β2γ2L and α4β3δ GABA-A receptor subtypes and inhibit estrus cycle-dependent aggressive behavior.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Umeå Neurosteroid Research Center, Department of Clinical Science, Umeå University, SE-901 85 Umea, Sweden.
- Asarina Pharma AB, Fogdevreten 2, SE-171 65 Solna, Sweden.
ORCID-Profile: Torbjörn Bäckström
Förderung
- CSRD VA
- Medical Research Council
- EU grant Horizon 2020 project
- Swedish research council
- University foundations
- Västerbotten läns landsting
- Kvinnoklinikens forskningsfond
Zitieren
APA
Bäckström, T., Bengtsson, S. K. S., Sjöstedt, J., Malinina, E., Johansson, M., Ragagnin, G., Ekberg, K., & Lundgren, P. (2023). Isoallopregnanolone Inhibits Estrus Cycle-Dependent Aggressive Behavior. Biomolecules. https://doi.org/10.3390/biom13061017
Vancouver
Bäckström T, Bengtsson SKS, Sjöstedt J, Malinina E, Johansson M, Ragagnin G, et al. Isoallopregnanolone Inhibits Estrus Cycle-Dependent Aggressive Behavior. Biomolecules. 2023. doi:10.3390/biom13061017
BibTeX
@article{Bckstrm2023,
author = {Bäckström, Torbjörn and Bengtsson, Sara K S and Sjöstedt, Jessica and Malinina, Evgenya and Johansson, Maja and Ragagnin, Gianna and Ekberg, Karin and Lundgren, Per},
title = {Isoallopregnanolone Inhibits Estrus Cycle-Dependent Aggressive Behavior},
journal = {Biomolecules},
year = {2023},
doi = {10.3390/biom13061017}
}
EUVIMED